BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21648175)

  • 21. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
    Fontaine PL; Saslow D; King VJ
    Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessing human papillomavirus vaccine efficacy and safety.
    Hendrix SL
    J Am Osteopath Assoc; 2008 Apr; 108(4 Suppl 2):S8-S12. PubMed ID: 18463363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
    Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
    Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines.
    Rangel LM; Ramírez M; Torroella M; Pedroza A; Ibarra V; Gariglio P
    Arch Med Res; 1994; 25(2):265-72. PubMed ID: 7919824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low rates of free human papillomavirus vaccine uptake among young women.
    Moore GR; Crosby RA; Young A; Charnigo R
    Sex Health; 2010 Sep; 7(3):287-90. PubMed ID: 20719216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 29. Human papillomavirus and genital cancer.
    Rapose A
    Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GARDASIL: prophylactic human papillomavirus vaccine development--from bench top to bed-side.
    Shi L; Sings HL; Bryan JT; Wang B; Wang Y; Mach H; Kosinski M; Washabaugh MW; Sitrin R; Barr E
    Clin Pharmacol Ther; 2007 Feb; 81(2):259-64. PubMed ID: 17259949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New quadrivalent HPV vaccine developments.
    Tovar JM; Bazaldua OV
    Postgrad Med; 2008 Nov; 120(4):14-6. PubMed ID: 19020361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus vaccine: an updated position statement of the Society for Adolescent Health and Medicine.
    Friedman L; Bell DL; Kahn JA; Marcell AV; Middleman AB; Rosenthal SL; Zimet GD
    J Adolesc Health; 2011 Feb; 48(2):215-6. PubMed ID: 21257124
    [No Abstract]   [Full Text] [Related]  

  • 33. Cervical cancer screening: from the Papanicolaou smear to the vaccine era.
    Crum CP; Abbott DW; Quade BJ
    J Clin Oncol; 2003 May; 21(10 Suppl):224s-230s. PubMed ID: 12743139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus genotype distributions inform screening and vaccination policy.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
    [No Abstract]   [Full Text] [Related]  

  • 36. HPV-vaccine and screening programs: the new era of global prevention.
    Mariani L
    J Prev Med Hyg; 2009 Jun; 50(2):90-5. PubMed ID: 20099438
    [No Abstract]   [Full Text] [Related]  

  • 37. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
    Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
    Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of examination offices in preventing genital cancer in women of retirement age].
    Alekhnovich MV
    Vopr Onkol; 1974; 20(9):103-6. PubMed ID: 4279497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.